| Patents for A61P 43 - Drugs for specific purposes, not provided for in groups (156,317) |
|---|
| 09/12/2007 | CN101035539A Novel uses of 2-phenyl-substituted imidazotriazinone derivatives |
| 09/12/2007 | CN101035530A VEGF inhibition |
| 09/12/2007 | CN101035520A CRP lowering agent |
| 09/12/2007 | CN101032615A Chinese traditional medicine for curing cold extremity and pain in waist and lower extremitiesг�’�ˆÁ€ÍðÊ® |
| 09/12/2007 | CN101032514A Method of preparing oxygen supplying solution for improving economy tissue |
| 09/12/2007 | CN101032497A Polyenylphosphatidylcholine freeze - dried powder injection for injecting and the preparing method thereof |
| 09/12/2007 | CN101032486A Medical plants intensifier having antifungal activity and drug tolerance of reversion azole antifungal agents |
| 09/12/2007 | CN101032474A Rasagiline transparent patch for curing and preventing neurological diseases and the preparing method thereof |
| 09/12/2007 | CN101032318A Seasoning of Chinese herbal medicine |
| 09/12/2007 | CN101032266A Teal oil including carotenoid and production method thereof |
| 09/12/2007 | CN100336537C Chinese medicinal composition for antifatigue and increasing immune power and its preparation method |
| 09/12/2007 | CN100336521C Composition comprising melissa leaf extract for anti-angiogenic and matrix metalloproteinase inhibitory activity |
| 09/12/2007 | CN100336458C Health-preserving preserved gastrodia tuber for middle aged and old aged people |
| 09/11/2007 | US7268213 Glucagon-like peptide-1 (glp-1) receptor agonist |
| 09/11/2007 | US7268210 PEG-LHRH analog conjugates |
| 09/11/2007 | US7268207 Nucleotide sequences coding polypeptide for use in the treatment of cancer |
| 09/11/2007 | US7268160 A therapeutic or prophylactic agent for a disease that requires enhancement of nerve growth factor production, e.g., butein; nervous system disorders; Alzeimher's disease; additive for foods, beverages and feeds |
| 09/11/2007 | US7268152 Antiinflammatory agents; antiallergens; antiproliferative agents |
| 09/11/2007 | US7268150 2-cyano-4-fluoropyrrolidine derivative or its salt |
| 09/11/2007 | US7268149 Cyclothiocarbamate derivatives as progesterone receptor modulators and methods of treating skin disorders |
| 09/11/2007 | US7268146 (3,4-Dihydro-1H-isoquinolin-2-yl)-[2-methyl-7-(2,4,6-trimethyl-phenyl)-4,5,6,7-tetrahydro-2H-pyrazolo[3,4-b]pyridin-3-yl]-methanone; Corticotropin releasing factor (CRF); stress-related illnesses, mood disorders such as depression, major depressive disorder, single episode depression |
| 09/11/2007 | US7268141 Xanthine phosphodiesterase V inhibitors |
| 09/11/2007 | US7268140 (2S)-1-((4-chlorophenoxy)methyl)carbonyl-2-methyl-4-(4-fluorobenzyl)piperazine; inhibit the activity of the chemokines, MIP-1 alpha and RANTES |
| 09/11/2007 | US7268132 Thio substituted with a hetero multiring group; sleepiness, promotion of wakefulness, Parkinson's disease, cerebral ischemia, stroke, sleep apneas, eating disorders, stimulation of appetite and weight gain, attention deficit hyperactivity disorder |
| 09/11/2007 | US7268129 Fluorinated benzothiadiazine compounds |
| 09/11/2007 | US7268128 Increase the intracellular cAMP level and further inhibit the activation of T cells; allergic diseases, inflammatory or immunological diseases |
| 09/11/2007 | US7268125 2-(azetidin-2-on-1-yl)alkanedioic acid esters and amides useful for treating disease states that are associated with and responsive to antagonism of a vasopressin V1a receptor in a mammal |
| 09/11/2007 | US7267977 Peripheral-type benzodiazepine receptor: a tool for detection, diagnosis, prognosis, and treatment of cancer |
| 09/11/2007 | US7267973 Nucleic acids encoding recombinant proteins containing Shiga-like toxin and vascular endothelial growth factor |
| 09/11/2007 | US7267822 Cytomodulating lipophilic peptides for modulating immune system activity and inhibiting inflammation |
| 09/11/2007 | US7267813 Inhalation particles incorporating a combination of two or more active ingredients |
| 09/11/2007 | CA2255858C Phenyl derivatives containing an acidic group, their preparation and their use as chloride channel blockers |
| 09/11/2007 | CA2187210C Method for purifying diacetylrhein |
| 09/11/2007 | CA2176935C Indole-derived azylpiperazines as ligands for 5ht1-like receptors 5ht1b and 5ht1d |
| 09/11/2007 | CA2164498C Assay for ykl-40 as a marker for degradation of mammalian connective tissue matrices |
| 09/07/2007 | WO2007100894A2 Fluvastatin sodium novel forms and preparation therof |
| 09/07/2007 | WO2007100103A1 Ameliorating agent for metabolic syndrome |
| 09/07/2007 | WO2007100091A1 Composition for suppressing the expression of fucosyltransferase |
| 09/07/2007 | WO2007100071A1 Npy y4 agonist as therapeutic agent for disease accompanied by intestinal tract dysfunction |
| 09/07/2007 | WO2007100066A1 17β HSD type 5 INHIBITOR |
| 09/07/2007 | WO2007099999A1 Novel glycolipid and use thereof |
| 09/07/2007 | WO2007099997A1 Immunostimulating agent and method for production thereof |
| 09/07/2007 | WO2007099981A1 Galactose derivative, drug carrier and medicinal composition |
| 09/07/2007 | WO2007099953A1 Tooth root formation promoter and method for promotion of tooth root formation |
| 09/07/2007 | WO2007099869A1 Therapeutic and preventive agent for hcv |
| 09/07/2007 | WO2007099852A1 Method of testing sensitivity of solid cancer against tyrosine kinase inhibitor and test kit therefor |
| 09/07/2007 | WO2007099828A1 Nirogenous heterocyclic derivatives substituted with cyclic groups |
| 09/07/2007 | WO2007099711A1 Differentiation inducer |
| 09/07/2007 | WO2007098541A1 Tissue regeneration ii |
| 09/07/2007 | WO2007064304A8 Biocompatible composition and uses thereof |
| 09/07/2007 | WO2002075302A8 Method for therapeutically treating a clinically recognized form of cardiopathology in a living mammal |
| 09/07/2007 | CA2644809A1 17 .beta. hsd type 5 inhibitor |
| 09/07/2007 | CA2643320A1 Modulators of muscarinic receptors |
| 09/07/2007 | CA2642180A1 Fluvastatin sodium novel forms and preparation therof |
| 09/07/2007 | CA2638943A1 Npy y4 agonist as therapeutic agent for disease accompanied by intestinal tract dysfunction |
| 09/07/2007 | CA2638797A1 Galactose derivative, drug carrier and medicinal composition |
| 09/06/2007 | US20070208179 Novel diphenylazetidinones, process for their preparation, medicaments comprising these compounds and their use |
| 09/06/2007 | US20070208077 Adiponectin Enhancer |
| 09/06/2007 | US20070208046 such as 4-benzyloxy-1-{4-[2-(dimethylamino)ethoxy]phenyl}-1H-pyridin-2-one, that as antagonists to melanin concentrating hormone receptors, used for treating cardiovascular, nervous system, metabolic, reproductive system, respiratory system and gatrointestinal disorders |
| 09/06/2007 | US20070208032 Chemical compounds |
| 09/06/2007 | US20070208016 1-(3-tert-butyl-4-methoxy-5-morpholinophenyl)-2-(5,6-diethoxy-7-fluoro-1-imino-1,3-dihydroisoindol-2-yl)ethanone,; stabilizing the composition; not decompose even when placed under humidification conditions |
| 09/06/2007 | US20070208008 Substituted sulfonamides and ureas useful for inhibiting kinase activity |
| 09/06/2007 | US20070208007 Amine-Based Compound and Use Thereof |
| 09/06/2007 | US20070207964 Combined use of a GLP-1 compound and another drug for treating dyslipidemia |
| 09/06/2007 | US20070207957 Composition For Accelerating Alcohol Metabolism Or Relieving Fatigue By Gluconeogenesis |
| 09/06/2007 | US20070207943 Interleukins-21 and 22 |
| 09/06/2007 | US20070207523 Mammalian t-type calcium channels |
| 09/06/2007 | US20070207462 Preventive/Remedy for Respiratory Diseases |
| 09/06/2007 | US20070207229 Inhibitor of blood glucose level elevation and inhibitor of age generation comprising acerola leaf extract and food product comprising either thereof |
| 09/06/2007 | US20070207160 Apoptosis inhibitors |
| 09/06/2007 | US20070207153 Therapeutic Agents For Inner Ear Disorders Containing An Il-6 Antagonist As An Active Ingredient |
| 09/06/2007 | US20070207131 Using a biodegradable acellular matrix, and passaged autologous fibroblasts substantially free of immunogenic proteins; therapy for degradation diseases; skin disorders; filling defects |
| 09/05/2007 | EP1829888A1 Anti-inflammatory compounds and uses thereof |
| 09/05/2007 | EP1829881A1 Combination of rapamycin and its tetrazole isomers and epimers, methods of making and using the same |
| 09/05/2007 | EP1829877A1 Bicyclic pyrrole derivatives |
| 09/05/2007 | EP1829863A1 Arylalkanoic acid derivative |
| 09/05/2007 | EP1829861A2 Pyrrolidine ester derivatives active as oxytocin antagonists |
| 09/05/2007 | EP1829858A2 Dibenzylamine compounds and pharmaceutical use thereof |
| 09/05/2007 | EP1829549A1 Amorphous composition |
| 09/05/2007 | EP1829542A1 Peroxisome proliferator-activated receptor (ppar) activator and drug, supplement, functional food and food additive using the same |
| 09/05/2007 | EP1829540A1 Preventive/therapeutic composition for liver disease |
| 09/05/2007 | EP1829529A1 Controlled release compositions of estradiol metabolites |
| 09/05/2007 | EP1829525A1 Composition and method for accelerating fibulin-5 production and/or enhancing fibulin-5 activity |
| 09/05/2007 | EP1827428A1 Compositions comprising an epothilone and production methods |
| 09/05/2007 | EP1827415A1 Use of substituted cyclopropane acid derivatives for producing drugs for use in the treatment of metabolic syndrome |
| 09/05/2007 | EP1827410A2 Bis(thio-hydrazide amides) for increasing hsp70 expression |
| 09/05/2007 | EP1827406A1 Anti-radical agents |
| 09/05/2007 | EP1539802B1 Novel kcnq polypeptides and their uses in the diagnosis of mental disorders |
| 09/05/2007 | EP1492796B1 Substituted amino isoxazoline derivatives and their use as anti-depressants. |
| 09/05/2007 | EP1487811B1 N-sulfonylurea apoptosis promoters |
| 09/05/2007 | EP1485475B1 Hybrid and single chain meganucleases and use thereof |
| 09/05/2007 | EP1474419B1 Amides of aminoalkyl-substituted azetidines, pyrrolidines, piperidines and azepanes |
| 09/05/2007 | EP1463760B1 Common lymphatic endothelial and vascular endothelial receptor-1 (clever-1) and uses thereof |
| 09/05/2007 | EP1410802B1 Cell death inducers for mast cells |
| 09/05/2007 | EP1373233B1 Derivatives of n-(arylsulfonyl)beta-aminoacids comprising a substituted aminomethyl group, the preparation method thereof and the pharmaceutical compositions containing same |
| 09/05/2007 | EP1345598B1 The use of rosiglitazone for treating psychiatric disorders. |
| 09/05/2007 | EP0757716B1 Dna encoding bradykinin b1 receptor |
| 09/05/2007 | EP0690918B1 Protein tyrosine phosphatase ptp-s31 |
| 09/05/2007 | CN101031297A Pharmaceutical composition for xerophthalmia and xerostomia treatment |
| 09/05/2007 | CN101031296A Modulators of muscarinic receptors |